NO923798L - Fremgangsmaate for fremstilling og anvendelse av nye acylaler av imidazol-5-karboksylsyrederivater - Google Patents

Fremgangsmaate for fremstilling og anvendelse av nye acylaler av imidazol-5-karboksylsyrederivater

Info

Publication number
NO923798L
NO923798L NO92923798A NO923798A NO923798L NO 923798 L NO923798 L NO 923798L NO 92923798 A NO92923798 A NO 92923798A NO 923798 A NO923798 A NO 923798A NO 923798 L NO923798 L NO 923798L
Authority
NO
Norway
Prior art keywords
carboxylic acid
imidazole
acylals
procedure
preparation
Prior art date
Application number
NO92923798A
Other languages
English (en)
Norwegian (no)
Other versions
NO923798D0 (no
Inventor
Dieter Binder
Josef Weinberger
Original Assignee
Chem Pharm Forsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chem Pharm Forsch Gmbh filed Critical Chem Pharm Forsch Gmbh
Publication of NO923798D0 publication Critical patent/NO923798D0/no
Publication of NO923798L publication Critical patent/NO923798L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO92923798A 1991-10-04 1992-09-30 Fremgangsmaate for fremstilling og anvendelse av nye acylaler av imidazol-5-karboksylsyrederivater NO923798L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0198791A AT398202B (de) 1991-10-04 1991-10-04 Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung

Publications (2)

Publication Number Publication Date
NO923798D0 NO923798D0 (no) 1992-09-30
NO923798L true NO923798L (no) 1993-04-05

Family

ID=3525398

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92923798A NO923798L (no) 1991-10-04 1992-09-30 Fremgangsmaate for fremstilling og anvendelse av nye acylaler av imidazol-5-karboksylsyrederivater

Country Status (22)

Country Link
US (1) US5298519A (ja)
EP (1) EP0535420A1 (ja)
JP (1) JP2544565B2 (ja)
CN (1) CN1032856C (ja)
AT (1) AT398202B (ja)
AU (1) AU649357B2 (ja)
CA (1) CA2079735A1 (ja)
CZ (1) CZ301992A3 (ja)
FI (1) FI924353A (ja)
HR (1) HRP920817A2 (ja)
HU (1) HUT62291A (ja)
IL (1) IL103329A (ja)
LV (1) LV10256B (ja)
MY (1) MY108350A (ja)
NO (1) NO923798L (ja)
NZ (1) NZ244320A (ja)
RU (1) RU2105764C1 (ja)
SI (1) SI9200240A (ja)
SK (1) SK301992A3 (ja)
TW (1) TW223073B (ja)
YU (1) YU48290B (ja)
ZA (1) ZA927205B (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2105939B1 (es) * 1994-08-02 1998-07-01 Uriach & Cia Sa J Nuevos pirazoles con actividad antagonista de la angiotensina ii.
CN101024643A (zh) * 2006-02-20 2007-08-29 上海艾力斯医药科技有限公司 咪唑－5－羧酸类衍生物、制备方法及其应用
CN101195615B (zh) * 2006-12-06 2013-03-27 深圳市信立泰资产管理有限公司 咪唑-5-羧酸衍生物的盐、制备方法及其药物组合物
EP2103610B1 (en) * 2006-12-06 2011-09-21 Shanghai Allist Pharmaceutical., Inc. Salts of imidazol-5-carboxylic acid derivatives, preparation methods and use thereof
CN101214242A (zh) * 2007-01-05 2008-07-09 上海艾力斯医药科技有限公司 新的药用组合物
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA3089569C (en) 2007-06-04 2023-12-05 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
CN101317842A (zh) 2007-06-07 2008-12-10 上海艾力斯医药科技有限公司 一种咪唑-5-羧酸衍生物的治疗用途
CN101367795B (zh) * 2007-08-17 2012-05-02 上海艾力斯生物医药有限公司 一种咪唑-5-羧酸衍生物及其制备方法
CN101407511B (zh) * 2007-10-11 2013-01-09 上海艾力斯生物医药有限公司 一种结晶型的咪唑-5-羧酸衍生物
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN103012377A (zh) * 2011-09-27 2013-04-03 江苏艾力斯生物医药有限公司 一种咪唑-5-羧酸酯的重结晶方法
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
RS65632B1 (sr) 2013-06-05 2024-07-31 Bausch Health Ireland Ltd Ultra-prečišćeni agonisti guanilat-ciklaze c, postupak njihove pripreme i upotrebe

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US5064825A (en) * 1989-06-01 1991-11-12 Merck & Co., Inc. Angiotensin ii antagonists
SG50669A1 (en) * 1989-06-30 1998-07-20 Du Pont Fused-ring aryl subtituted imidazoles
EP0411507B1 (en) * 1989-08-02 1994-10-26 Takeda Chemical Industries, Ltd. Pyrazole derivatives, their production and use
DE4132631A1 (de) * 1991-10-01 1993-04-08 Bayer Ag Imidazolyl-propensaeurederivate
DE4132632A1 (de) * 1991-10-01 1993-04-08 Bayer Ag Substituierte imidazolyl-propensaeurederivate
DE69329982T2 (de) * 1992-06-02 2001-09-27 Sankyo Co., Ltd. 4-Carboxyimidazolderivate als Angiotensin-II-Antagonisten und ihre therapeutische Verwendung

Also Published As

Publication number Publication date
RU2105764C1 (ru) 1998-02-27
AU2617692A (en) 1993-04-08
LV10256A (lv) 1994-10-20
HUT62291A (en) 1993-04-28
JP2544565B2 (ja) 1996-10-16
IL103329A0 (en) 1993-03-15
EP0535420A1 (de) 1993-04-07
CN1032856C (zh) 1996-09-25
JPH05310731A (ja) 1993-11-22
CZ301992A3 (en) 1993-08-11
FI924353A0 (fi) 1992-09-29
YU48290B (sh) 1998-05-15
US5298519A (en) 1994-03-29
SI9200240A (en) 1993-06-30
CN1071426A (zh) 1993-04-28
MY108350A (en) 1996-09-30
TW223073B (ja) 1994-05-01
NO923798D0 (no) 1992-09-30
SK301992A3 (en) 1995-10-11
YU87592A (sh) 1995-10-03
NZ244320A (en) 1995-01-27
LV10256B (en) 1995-04-20
AT398202B (de) 1994-10-25
CA2079735A1 (en) 1993-04-05
ZA927205B (en) 1993-03-23
AU649357B2 (en) 1994-05-19
ATA198791A (de) 1994-02-15
HU9203149D0 (en) 1992-12-28
HRP920817A2 (en) 1996-08-31
IL103329A (en) 1996-10-31
FI924353A (fi) 1993-04-05

Similar Documents

Publication Publication Date Title
NO923798L (no) Fremgangsmaate for fremstilling og anvendelse av nye acylaler av imidazol-5-karboksylsyrederivater
MXPA04006003A (es) Derivados del acido fenilpropionico substituidos como agonistas al receptor alfa activado-proliferativo de peroxisoma (ppar) humano.
MXPA03010435A (es) Derivados de oxazol acido carboxilico sustituidos para uso como activadores de proliferacion del peroximosa(ppar-alfa y gama) en el tratamiento de diabetes.
NO20051265L (no) Anvendelse av og noen nye imidazopyridiner
IL179634A0 (en) 5-substituted-2-phenylamino-benzamides as mek inhibitor
IL166412A0 (en) Novel use of benzothiazole derivatives
NO20055655L (no) Anvendelse av azetidinkarboksamidderivater i terapi
IL169257A0 (en) Cycloalkene dicarboxylic acid compounds as anti-infammatory, immunomodulatory and anti-proliferatory agents
HK1076107A1 (en) Pyrrolidine derivatives as oxytocin antagonists
WO2005066167A3 (en) 3-quinuclidinyl heteroatom bridged biaryl derivatives
DK0538192T3 (da) Hidtil ukendte 17beta-substituerede aza-androstan-derivater
MX2024003130A (es) Amida 1,4-dihidro-1,6-naftiridina sustituida y uso de la misma.
DK0526313T3 (da) Nye ureaderivater, deres fremstilling og terapeutiske anvendelse
DE50304891D1 (de) N-aryl-4,5-diaminopyrazole und diese verbindungen enthaltende färbemittel
SE0104333D0 (sv) Therapeutic agents
MXPA02003952A (es) Derivados de imidazol como inhibidores de la fosfodieterasa vii.
BG106520A (en) Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity
DE60324401D1 (de) Iodierte triglycerid-derivate
ATE446284T1 (de) Indolderivate mit einer acetylengruppe als ppar- aktivatoren
CO5021214A1 (es) Derivado del acido 2-metilpropionico y composicion farmaceutica que lo contiene
NO20061819L (no) Ligander
HUP0300391A2 (hu) Prosztaglandinnal rokon vegyületek alkalmazása szemen belüli túlnyomás és glaukóma kezelésére alkalmas készítmény előállítására
DK0622372T3 (da) Hidtil ukendt forbindelse, Leustroducsin H, dens fremstilling og dens terapeutiske anvendelse
TH50555A (th) อนุพันธ์อิมิดาโซไพริดินที่เป็นตัวยับยั้งฟอสฟอไดเอสเทอเรส vii
PL1637537T3 (pl) Nowe leki